BridgeBio Pharma, Inc. Reports annual revenue of $9.3 million
Company Records $653.3 million loss
By USInMinutes
Published - Mar 05, 2024, 09:14 AM ET
Last Updated - Mar 05, 2024, 09:14 AM EST
BridgeBio Pharma, Inc. [BBIO] has reported $9.3 million in revenue for year ended Dec 31, 2023.
Also Read:
